Copenhagen based Genmab nominated for 2005 biotech award  

Biotech company Genmab based in Copenhagen has been nominated for the 2005 World Technology Award for Biotechnology

Copenhagen based biotech company Genmab has been nominated for the 2005 World Technology Award for Biotechnology. The prize will be given to the most innovative company, with the greatest importance for the biotech industry in the long term.

Helle Husted, director of investor relations at Genmab comments to financial daily newspaper Børsen: "It is satisfying to be nominated because it shows that companies in our own industry have noticed us". The winner will be announced at the World Technology Summit on 14-15 November in San Francisco, USA.

Genmab creates and develops human antibodies for the treatment of life-threatening and debilitating diseases such as cancer and rheumatoid arthritis. Genmab has partnership agreements with companies such as Roche and Amgen. In addition to Genmab's activities in Denmark, it has operations in Utrecht, Holland and Princeton, New Jersey in the US.

Link > Genmab 

Next step

Explore business cases

Please contact me

How can we help you?

We use cookies to make the website perform optimally. You accept cookies by closing the box or continuing to use the website. Click here to read more about cookies. ×